U.S. IPO market bracing for second-biggest deal of the year so far in eyecare health company Bausch + Lomb

The U.S. initial public offering market is bracing for what is expected to be the second-biggest deal of the year so far this week, that of eyecare company Bausch + Lomb, which is expected to raise up to $840 million at a valuation of more than $8 billion.